arXiv subjects

Seungjun Ahn

Publications and source records attributed to Seungjun Ahn.

9 recordsLinked to original sources

arXiv2026

A Zero-Inflated Beta Mixture Model for Marginal Mediation Analysis with Compositional Microbiome Mediators

The role of the microbiome in disease pathogenesis is an emerging field with strong evidence suggesting that dysbiosis is associated with precancerous and cancerous states. Microbiome data present substantial challenges for causal mediation analysis due to sparsity, compositional constraints, and latent heterogeneity. To address these issues, we propose a zero-inflated beta mixture (ZIBM) method for mediation analysis with compositional microbiome mediators. The proposed method accommodates excess zeros through a zero-inflation component and captures heterogeneity in non-zero relative abundances using a beta mixture distribution. Within the potential-outcomes framework, the ZIBM provides estimates of marginal microbiome-mediated causal effects, and model parameters are estimated using an expectation-maximization algorithm. Simulation studies demonstrate that the ZIBM yields more accurate estimation and reliable inference under conditions commonly observed in microbiome data, compared with existing approaches. An application to a real microbiome study further illustrates its practical utility. These results indicate that the proposed method provides a more flexible and robust statistical framework for mediation analysis involving compositional microbiome data.

stat.ME↗

arXiv2026

A Quasi-Regression Method for the Mediation Analysis of Zero-Inflated Single-Cell Data

Recent advances in single-cell technologies have advanced our understanding of gene regulation and cellular heterogeneity at single-cell resolution. Single-cell data contain both gene expression levels and the proportion of expressing cells, which makes them structurally different from bulk data. Currently, methodological work on causal mediation analysis for single-cell data remains limited and often requires specific distributional assumptions. To address this challenge, we present QuasiMed, a mediation framework specialized for single-cell data. Our proposed method comprises three steps, including (i) screening mediator candidates through penalized regression and marginal models (similar to sure independence screening), (ii) estimation of indirect effects through the average expression and the proportion of expressing cells, (iii) and hypothesis testing with multiplicity control. The key benefit of QuasiMed is that it specifies only the mean functions of the mediation models through a quasi-regression framework, thereby relaxing strict distributional assumptions. The method performance was evaluated through the real-data-inspired simulations, and demonstrated high power, false discovery rate control, and computational efficiency. Lastly, we applied QuasiMed to ROSMAP single-cell data to illustrate its potential to identify mediating causal pathways. R package is freely available on GitHub repository at https://github.com/sjahnn/QuasiMed.

stat.ME↗

arXiv2025

CHIMA: a correlation-aware high-dimensional mediation analysis with its application to the living brain project study

Mediation analysis examines the pathways through which mediators transmit the effect of an exposure to an outcome. In high-dimensional settings, the joint significance test is commonly applied using variable screening followed by statistical inference. However, when mediators are highly correlated, existing methods may experience reduced statistical power due to inaccurate screening and residual bias in asymptotic inference. To address these issues, we propose CHIMA (Correlation-aware High-dimensional Mediation Analysis), an extension of a recently developed high-dimensional mediation analysis framework that enhances performance under correlation by integrating two advances: (i) high-dimensional ordinary least squares projection for accurate screening under correlation; and (ii) approximate orthogonalization for bias reduction. Simulation studies demonstrate that CHIMA effectively identifies active mediators even in the presence of strong correlations and outperforms competing methods across various settings. We further apply CHIMA to ribonucleic acid sequencing (RNA-seq) from the Living Brain Project, identifying genes that mediate the effect of Parkinson's disease on brain cell composition, thereby revealing cell-type-specific mechanisms of disease.

stat.ME↗

arXiv2025

A Statistical Framework for Co-Mediators of Zero-Inflated Single-Cell RNA-Seq Data

Single-cell RNA sequencing (scRNA-seq) has revolutionized the study of cellular heterogeneity, enabling detailed molecular profiling at the individual cell level. However, integrating high-dimensional single-cell data into causal mediation analysis remains challenging due to zero inflation and complex mediator structures. We propose a novel mediation framework leveraging zero-inflated negative binomial models to characterize cell-level mediator distributions and beta regression for zero-inflation proportions. The model can identify expression level as well as expressed proportion that could mediate disease-leading causal pathway. Extensive simulation studies demonstrate improved power and controlled false discovery rates. We further illustrate the utility of this approach through application to ROSMAP single-cell transcriptomic data, uncovering biologically meaningful mediation effects that enhance understanding of disease mechanisms.

stat.ME↗

arXiv2025

A Network-Guided Penalized Regression with Application to Proteomics Data

Network theory has proven invaluable in unraveling complex protein interactions. Previous studies have employed statistical methods rooted in network theory, including the Gaussian graphical model, to infer networks among proteins, identifying hub proteins based on key structural properties of networks such as degree centrality. However, there has been limited research examining a prognostic role of hub proteins on outcomes, while adjusting for clinical covariates in the context of high-dimensional data. To address this gap, we propose a network-guided penalized regression method. First, we construct a network using the Gaussian graphical model to identify hub proteins. Next, we preserve these identified hub proteins along with clinically relevant factors, while applying adaptive Lasso to non-hub proteins for variable selection. Our network-guided estimators are shown to have variable selection consistency and asymptotic normality. Simulation results suggest that our method produces better results compared to existing methods and demonstrates promise for advancing biomarker identification in proteomics research. Lastly, we apply our method to the Clinical Proteomic Tumor Analysis Consortium (CPTAC) data and identified hub proteins that may serve as prognostic biomarkers for various diseases, including rare genetic disorders and immune checkpoint for cancer immunotherapy.

stat.ME↗

arXiv2025

Leveraging Two-Phase Data for Improved Prediction of Survival Outcomes with Application to Nasopharyngeal Cancer

Accurate survival predicting models are essential for improving targeted cancer therapies and clinical care among cancer patients. In this article, we investigate and develop a method to improve predictions of survival in cancer by leveraging two-phase data with expert knowledge and prognostic index. Our work is motivated by two-phase data in nasopharyngeal cancer (NPC), where traditional covariates are readily available for all subjects, but the primary viral factor, Human Papillomavirus (HPV), is substantially missing. To address this challenge, we propose an expert guided method that incorporates prognostic index based on the observed covariates and clinical importance of key factors. The proposed method makes efficient use of available data, not simply discarding patients with unknown HPV status. We apply the proposed method and evaluate it against other existing approaches through a series of simulation studies and real data example of NPC patients. Under various settings, the proposed method consistently outperforms competing methods in terms of c-index, calibration slope, and integrated Brier score. By efficiently leveraging two-phase data, the model provides a more accurate and reliable predictive ability of survival models.

stat.ME↗

arXiv2025

A Multi-Omics Framework for Survival Mediation Analysis of High-Dimensional Proteogenomic Data

Survival analysis plays a crucial role in understanding time-to-event (survival) outcomes such as disease progression. Despite recent advancements in causal mediation frameworks for survival analysis, existing methods are typically based on Cox regression and primarily focus on a single exposure or individual omics layers, often overlooking multi-omics interplay. This limitation hinders the full potential of integrated biological insights. In this paper, we propose SMAHP, a novel method for survival mediation analysis that simultaneously handles high-dimensional exposures and mediators, integrates multi-omics data, and offers a robust statistical framework for identifying causal pathways on survival outcomes. This is one of the first attempts to introduce the accelerated failure time (AFT) model within a multi-omics causal mediation framework for survival outcomes. Through simulations across multiple scenarios, we demonstrate that SMAHP achieves high statistical power, while effectively controlling false discovery rate (FDR), compared with two other approaches. We further apply SMAHP to the largest head-and-neck carcinoma proteogenomic data, detecting a gene mediated by a protein that influences survival time.

stat.ME↗

arXiv2023

Differential Co-Abundance Network Analyses for Microbiome Data Adjusted for Clinical Covariates Using Jackknife Pseudo-Values

A recent breakthrough in differential network (DN) analysis of microbiome data has been realized with the advent of next-generation sequencing technologies. The DN analysis disentangles the microbial co-abundance among taxa by comparing the network properties between two or more graphs under different biological conditions. However, the existing methods to the DN analysis for microbiome data do not adjust for other clinical differences between subjects. We propose a Statistical Approach via Pseudo-value Information and Estimation for Differential Network Analysis (SOHPIE-DNA) that incorporates additional covariates such as continuous age and categorical BMI. SOHPIE-DNA is a regression technique adopting jackknife pseudo-values that can be implemented readily for the analysis. We demonstrate through simulations that SOHPIE-DNA consistently reaches higher recall and F1-score, while maintaining similar precision and accuracy to existing methods (NetCoMi and MDiNE). Lastly, we apply SOHPIE-DNA on two real datasets from the American Gut Project and the Diet Exchange Study to showcase the utility. The analysis of the Diet Exchange Study is to showcase that SOHPIE-DNA can also be used to incorporate the temporal change of connectivity of taxa with the inclusion of additional covariates. As a result, our method has found taxa that are related to the prevention of intestinal inflammation and severity of fatigue in advanced metastatic cancer patients.

stat.ME↗

arXiv2022

A Pseudo-Value Regression Approach for Differential Network Analysis of Co-Expression Data

The differential network (DN) analysis identifies changes in measures of association among genes under two or more experimental conditions. In this article, we introduce a Pseudo-value Regression Approach for Network Analysis (PRANA). This is a novel method of differential network analysis that also adjusts for additional clinical covariates. We start from mutual information (MI) criteria, followed by pseudo-value calculations, which are then entered into a robust regression model. This article assesses the model performances of PRANA in a multivariable setting, followed by a comparison to dnapath and DINGO in both univariable and multivariable settings through variety of simulations. Performance in terms of precision, recall, and F1 score of differentially connected (DC) genes is assessed. By and large, PRANA outperformed dnapath and DINGO, neither of which is equipped to adjust for available covariates such as patient-age. Lastly, we employ PRANA in a real data application from the Gene Expression Omnibus (GEO) database to identify DC genes that are associated with chronic obstructive pulmonary disease (COPD) to demonstrate its utility. To the best of our knowledge, this is the first attempt of utilizing a regression modeling for DN analysis by collective gene expression levels between two or more groups with the inclusion of additional clinical covariates. By and large, adjusting for available covariates improves accuracy of a DN analysis.

stat.ME↗